Pharmacy Business Funding: Options and Who Qualifies
An independent pharmacy's funding problem is almost never profitability. It is timing. You buy inventory from a wholesaler and pay for it on the wholesaler's terms, while the money for the drugs you dispense arrives later from a third-party payer. The business can be sound on paper and still be short of cash in the account on the day the wholesaler invoice comes due.
Byzfunder funds businesses directly, from our own balance sheet. We have funded over $2B to more than 35,000 businesses since 2019, and pharmacy is one of the healthcare categories we see most.
- The core pharmacy cash-flow problem is the gap between paying the wholesaler and collecting third-party reimbursement
- Working capital for a pharmacy is usually sized against deposit history, not against real estate or inventory as collateral
- An MCA is a purchase of future receivables at a fixed factor rate, repaid on a fixed debit agreed before funding - it is not a loan and has no APR
- ByzFlex is revenue-based revolving capital, suited to a gap that recurs rather than a single one-time purchase
The gap between paying the wholesaler and getting reimbursed
Start here, because everything else in a pharmacy's capital picture sits downstream of it.
Inventory leaves your cash account before the prescription is even written. You stock against expected demand, the wholesaler bills on its own terms, and that invoice is due on a date set by the wholesaler's agreement, not by your collections. Then you dispense. The patient's copay arrives at the counter; the far larger remainder comes from a third-party payer after a claim has been adjudicated. The reimbursement is not simultaneous with the purchase, and the pharmacy carries the difference out of its own working capital.
Most independents manage this gap routinely. The trouble starts when something stretches it:
A large brand-name or specialty order. A single order of a high-cost brand-name or specialty drug can tie up more cash than a week of ordinary inventory. The margin on that order may be thin, but the cash outlay is not. One or two of these in the same buying cycle can absorb the buffer a pharmacy spent months building.
Reimbursement adjustments that land after the fact. Direct and indirect remuneration fees and other post-adjudication adjustments are assessed after dispensing, which means a pharmacy can be reconciling a reduction against revenue it already recognised and inventory it already paid for. The accounting catches up; the cash position has already moved.
A payer slowdown or a claims dispute. When one payer's remittances run late, every wholesaler invoice in that window is suddenly competing with payroll for the same deposits.
Growth itself. Picking up a long-term-care contract, a new prescriber's volume, or a block of patients from a store that closed all require buying more inventory before any of the new dispensing is reimbursed. Growing a pharmacy consumes cash before it produces it.
None of this makes a pharmacy a weak business. It makes a pharmacy a business whose working capital is structurally committed to inventory it has not yet been paid for — which is exactly the situation external working capital exists to cover. If that is the shape of your month, you can start an application with three to six months of statements and no appraisal.
Why bank underwriting often misreads a pharmacy
Traditional lending wants an asset to secure. A pharmacy's balance sheet is heavy on inventory that depreciates on a shelf life, plus fixtures and a dispensing system, and most independents lease their space. There is frequently nothing a conventional lender treats as strong collateral.
Underwriting against deposit history inverts the test. A pharmacy with consistent daily deposits across three to six months is demonstrating that it dispenses and that it collects. That is a more direct read on whether capital can be repaid than a collateral schedule is.
What independent pharmacies use working capital for
- Covering a wholesaler invoice when reimbursement for the inventory it bought has not yet landed.
- Funding a large brand-name or specialty order without draining the account that payroll runs from.
- Building out compounding — the hood, the dedicated space, the training and the documentation work.
- Standing up immunisation or point-of-care testing, including the refrigeration, the scheduling capability and the staff time to run it.
- Hiring a second pharmacist or an additional technician, where the payroll starts immediately and the extra dispensing volume builds over months.
- Buying an independent store from a retiring owner, or funding the deposit and transition costs around that purchase.
- Covering payroll through a payer slowdown, which is the most common reason a profitable pharmacy calls.
The three structures we offer
A merchant cash advance (MCA) is a purchase of a portion of your future receivables at a fixed factor rate. It is not a loan and it carries no APR, because it is not interest-bearing — it is a sale of receivables. Repayment is a fixed debit on an agreed schedule, taken automatically, and both the amount and the day are set before you sign. For a defined, dated need — a specific wholesaler cycle, a specific large order — knowing the exact figure in advance is the point. An MCA does create a real repayment obligation, and it should be sized against a slow week rather than your best one.
ByzFlex is revenue-based revolving capital. It is not a line of credit. You request capital, use it, and can use it again as it is repaid. For a pharmacy that is the better fit when the gap recurs — a buying cycle that tightens every month, seasonal immunisation demand, a payer whose remittances are reliably slow — rather than one purchase you can name.
A term loan is the simplest structure: a fixed amount on a fixed schedule for a project with a known cost, such as a build-out or an acquisition. Term loans are advertised by Byzfunder and fulfilled through our affiliated Byzwash entity.
How the realistic options compare
| Option | What it is | Best fit for a pharmacy | Trade-off |
|---|---|---|---|
| Merchant cash advance (Byzfunder) | Purchase of future receivables at a fixed factor rate. Not a loan, no APR. | A dated, specific need: a wholesaler cycle, a large brand-name or specialty order. | Generally costs more than bank credit; the debit is fixed and does not pause. |
| ByzFlex (Byzfunder) | Revenue-based revolving capital, used and reused as it is repaid. | A gap that recurs each buying cycle or season. | Revolving access requires the discipline not to treat it as permanent capital. |
| Term loan (advertised by Byzfunder, fulfilled via Byzwash) | Fixed amount, fixed schedule. | A build-out, a compounding room, buying a store. | Less useful for a gap that moves week to week. |
| Bank or credit union loan | Conventional secured or underwritten credit. | A pharmacy with real estate, strong credit and time to wait. | Slow, and often wants collateral an independent does not have. |
| SBA loan (offered by other providers, not by Byzfunder) | A loan through a participating lender, backed in part by the SBA. | A large acquisition where the timeline allows a long process. | Documentation-heavy and slow relative to a cash-flow gap. |
| Equipment financing (offered by other providers, not by Byzfunder) | Financing secured by the equipment itself. | A single large hardware purchase. | Only covers the equipment — not inventory, not payroll. |
Two of those we do not offer, and we have marked them as such. They are listed because a pharmacy owner comparing options should see the whole field, and because the right answer sometimes is the slower, cheaper one. Speed is worth paying for when the need is dated and the bank's answer is weeks away; it is not worth paying for when you have a year to plan a build-out. If you want to see what the faster path would look like for your numbers, you can send your statements over and get a read without committing.
What you will need
Three to six months of business bank statements, a completed application, and basic business details. No appraisal and no inventory audit. A complete file can fund in as little as 24 hours.
Qualification factors we read:
- Business deposits. Typically about $20,000 a month or more, read across three to six months of statements.
- Credit. A 525 FICO floor for an MCA, 550 for ByzFlex. It is one input among several, not a pass mark on its own.
- A US-based business with a business bank account.
- Time in business. Longer helps, but the deposit record carries more weight than the founding date.
Every file is underwritten on its own merits. Approval is never promised, and we do not quote an amount before reading the statements. Some files are a better fit elsewhere, and we will say so.
Frequently asked questions
Why do pharmacies need working capital if they are profitable? Because profit and cash are on different clocks. Inventory is paid for on the wholesaler's terms while the bulk of the revenue for it arrives later from a third-party payer. A pharmacy can be profitable over a quarter and still be short on a specific Tuesday.
Is a merchant cash advance a loan? No. It is a purchase of a portion of your future receivables at a fixed factor rate, so it carries no APR and is not interest-bearing. The repayment amount and schedule are fixed and agreed before funding, which is why it is possible to plan around. A term loan is a loan; those are advertised by Byzfunder and fulfilled through our affiliated Byzwash entity.
Do I need to pledge my inventory or my real estate? No. Underwriting reads deposit history rather than a collateral schedule, which is the main reason this structure works for independents who lease their space. There is no appraisal and no inventory audit in the file.
Can I use it for one large specialty or brand-name order? Yes, and a single dated order is a textbook use for an MCA, because the amount and the repayment are both known before you commit. If the squeeze comes back every buying cycle instead, ByzFlex is usually the better structure. You can talk it through with underwriting before choosing.
What does paying off early cost? Paying off early earns a 2.99% discount on our paper. Ask for the exact figure on your offer before you sign, and compare the total repayment amount across any offers you are weighing.